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Summary {#efs24668-sec-0001}
=======

Commission Implementing Regulation (EU) No 844/2012 (hereinafter referred to as 'the Regulation') lays down the procedure for the renewal of the approval of active substances submitted under Article 14 of Regulation (EC) No 1107/2009. The list of those substances is established in Commission Implementing Regulation (EU) No 686/2012. *Pseudomonas chlororaphis* strain MA 342 is one of the active substances listed in Regulation (EU) No 686/2012.

In accordance with Article 1 of the Regulation, the rapporteur Member State (RMS), the Netherlands, and co‐rapporteur Member State (co‐RMS), Denmark, received an application from Lantmännen BioAgri AB for the renewal of approval of the active substance *Pseudomonas chlororaphis* strain MA 342. Complying with Article 8 of the Regulation, the RMS checked the completeness of the dossier and informed the applicant, the co‐RMS (Denmark), the European Commission and the European Food Safety Authority (EFSA) about the admissibility.

The RMS provided its initial evaluation of the dossier on *P. chlororaphis* strain MA 342 in the renewal assessment report (RAR), which was received by EFSA on 18 December 2015. In accordance with Article 12 of the Regulation, EFSA distributed the RAR to the Member States and the applicant, Lantmännen BioAgri AB, for comments on 9 February 2016. EFSA also provided comments. In addition, EFSA conducted a public consultation on the RAR. EFSA collated and forwarded all comments received to the European Commission on 13 April 2016.

Following consideration of the comments received on the RAR, it was concluded that additional information should be requested from the applicant, and that EFSA should conduct an expert consultation in the areas of mammalian toxicology, environmental fate and behaviour, and ecotoxicology.

In accordance with Article 13(1) of the Regulation, EFSA should adopt a conclusion on whether *P. chlororaphis* strain MA 342 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 of the European Parliament and of the Council.

The conclusions laid down in this report were reached on the basis of the evaluation of the representative uses of *P. chlororaphis* strain MA 342 as a seed treatment in cereals (wheat, rye and triticale), carrots and peas against seed‐borne diseases and foliar application in cereals against foliar and ear pathogens, as proposed by the applicant. Full details of the representative uses can be found in Appendix [A](#efs24668-sec-0021){ref-type="sec"} of this report.

Data were submitted to conclude that the representative uses proposed for *P. chlororaphis* strain MA 342 at the European Union (EU) level result in a sufficient fungicidal efficacy against seed‐borne diseases in cereals, carrots and peas, and against foliar and ear pathogens in cereals.

With regard to the review of the scientific peer‐reviewed open literature on the active substance and its relevant metabolites, a data gap was identified for an updated search dealing with side effects on non‐target species.

Data gaps were identified for the suspensibility determination of the formulation for the determination of the growth temperatures of *P. chlororaphis* strain MA 342 and to prove that besides 2,3‐deepoxy‐2,3‐didehydro‐rhizoxin (DDR) no relevant secondary metabolites/toxins are produced.

In the mammalian toxicology, several data gaps were identified: information to show that a potential transfer of genetic material will not lead to unacceptable effects on human and animal health; a new acute oral toxicity study addressing the infectivity and the clearance and further considerations on the derivation of reference values for the genotoxic metabolite DDR. The risk assessment for workers and residents related to exposure to DDR and unknown secondary metabolites/toxins could not be finalised.

In residues, in relation to the use of *P. chlororaphis* strain MA 342, the relevance of viable residues for consumers is pending finalisation of the assessment of effects on human health. Moreover, non‐viable residues were found to be relevant since a metabolite DDR with mutagenic properties was identified. On the basis of the currently available data and information, a refinement of the consumer risk assessment is not possible. In a first tier assessment using the threshold of toxicological concern (TTC) approach, consumer safety could not be demonstrated (critical area of concern) and specific toxicological reference values should be derived for metabolite DDR.

A number of data gaps have been identified with respect to the fate and behaviour of the microorganism into the environment: information regarding viability/population dynamics, information in relation to the mobility of the microorganism in the environment, information to show that a potential transfer of genetic material will not lead to unacceptable effects on the environment and information in relation to potential interference with the analytical systems for the control of the quality of drinking water (issue not finalised). Another issue not finalised was identified regarding the assessment of potential groundwater exposure by toxins/secondary metabolites.

In the area of ecotoxicology, data gaps were identified for further information to address the risk from *P. chlororaphis* strain MA 342 and metabolite DDR to birds and wild mammals, aquatic organisms, honeybees, non‐target arthropods and soil macro‐ and microorganisms.

Background {#efs24668-sec-0003}
==========

Commission Implementing Regulation (EU) No 844/2012[1](#efs24668-note-1004){ref-type="fn"} (hereinafter referred to as 'the Regulation') lays down the provisions for the procedure of the renewal of the approval of active substances, submitted under Article 14 of Regulation (EC) No 1107/2009[2](#efs24668-note-2002){ref-type="fn"}. This regulates for the European Food Safety Authority (EFSA) the procedure for organising the consultation of the Member States, the applicant(s) and the public on the initial evaluation provided by the rapporteur Member State (RMS) and/or co‐rapporteur Member State (co‐RMS) in the renewal assessment report (RAR), and the organisation of an expert consultation where appropriate.

In accordance with Article 13 of the Regulation, unless formally informed by the European Commission that a conclusion is not necessary, EFSA is required to adopt a conclusion on whether the active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 within 5 months from the end of the period provided for the submission of written comments, subject to an extension of up to 3 months where additional information is required to be submitted by the applicant(s) in accordance with Article 13(3).

In accordance with Article 1 of the Regulation, the RMS the Netherlands and co‐RMS Denmark received an application from Lantmännen BioAgri AB for the renewal of approval of the active substance *Pseudomonas chlororaphis* strain MA 342. Complying with Article 8 of the Regulation, the RMS checked the completeness of the dossier and informed the applicant, the co‐RMS (Denmark), the European Commission and EFSA about the admissibility.

The RMS provided its initial evaluation of the dossier on *P. chlororaphis* strain MA 342 in the RAR, which was received by EFSA on 18 December 2015 (Netherlands, [2015](#efs24668-bib-0013){ref-type="ref"}).

In accordance with Article 12 of the Regulation, EFSA distributed the RAR to the Member States and the applicant, Lantmännen BioAgri AB, for consultation and comments on 9 February 2016. EFSA also provided comments. In addition, EFSA conducted a public consultation on the RAR. EFSA collated and forwarded all comments received to the European Commission on 13 April 2016. At the same time, the collated comments were forwarded to the RMS for compilation and evaluation in the format of a reporting table. The applicant was invited to respond to the comments in column 3 of the reporting table. The comments and the applicant\'s response were evaluated by the RMS in column 3.

The need for expert consultation and the necessity for additional information to be submitted by the applicant in accordance with Article 13(3) of the Regulation were considered in a telephone conference between EFSA and the RMS on 26 May 2016. On the basis of the comments received, the applicant\'s response to the comments and the RMS\'s evaluation thereof, it was concluded that additional information should be requested from the applicant, and that EFSA should conduct an expert consultation in the areas of mammalian toxicology, environmental fate and behaviour, and ecotoxicology.

The outcome of the telephone conference, together with EFSA\'s further consideration of the comments, is reflected in the conclusions set out in column 4 of the reporting table. All points that were identified as unresolved at the end of the comment evaluation phase and which required further consideration, including those issues to be considered in an expert consultation, were compiled by EFSA in the format of an evaluation table.

The conclusions arising from the consideration by EFSA, and as appropriate by the RMS, of the points identified in the evaluation table, together with the outcome of the expert consultation and the written consultation on the assessment of additional information, where these took place, were reported in the final column of the evaluation table.

A final consultation on the conclusions arising from the peer review of the risk assessment took place with the Member States via a written procedure in November 2016.

This conclusion report summarises the outcome of the peer review of the risk assessment of the active substance and the representative formulation, evaluated on the basis of the representative uses of *P. chlororaphis* strain MA 342 as a seed treatment in cereals (wheat, rye and triticale), carrots and peas against seed‐borne diseases and foliar application in cereals against foliar and ear pathogens, as proposed by the applicant. A list of the relevant end points for the active substance and the formulation is provided in Appendix [A](#efs24668-sec-0021){ref-type="sec"}.

In addition, a key supporting document to this conclusion is the peer review report (EFSA, [2016](#efs24668-bib-0005){ref-type="ref"}), which is a compilation of the documentation developed to evaluate and address all issues raised in the peer review, from the initial commenting phase to the conclusion. The peer review report comprises the following documents, in which all views expressed during the course of the peer review, including minority views, where applicable, can be found: the comments received on the RAR;the reporting table (30 May 2016);the evaluation table (5 December 2016);the report(s) of the scientific consultation with the Member State experts (where relevant);the comments received on the assessment of the additional information (where relevant);the comments received on the draft EFSA conclusion.

Given the importance of the RAR, including its revisions (Netherlands, [2016](#efs24668-bib-0014){ref-type="ref"}), and the peer review report, both documents are considered as background documents to this conclusion and thus are made publicly available.

It is recommended that this conclusion report and its background documents would not be accepted to support any registration outside the European Union (EU) for which the applicant has not demonstrated that it has regulatory access to the information on which this conclusion report is based.

The identity of the microorganism and the properties of the formulated product {#efs24668-sec-0004}
==============================================================================

*Pseudomonas chlororaphis* strain MA 342 bacterium is deposited at the culture collection of the UK National Collection of Industrial and Marine Bacteria Ltd (NCIMB) under the accession number NCIMB 40616. It is a wild‐type strain isolated from roots of wild crowberry (*Empetrum nigrum* L.) in Sweden.

The representative microbial pest control product (MPCP) for the evaluation was 'Cerall', a flowable concentrate for seed treatment (FS) containing 5 × 10^12^ colony‐forming units (CFU)/kg (200 g/kg, min. 1 × 10^12^ CFU/kg, max. 1 × 10^13^ CFU/kg) *P. chlororaphis* strain MA 342.

The representative uses evaluated comprise applications as a fungicide as seed treatment in cereals (wheat, rye and triticale), carrots and peas against seed‐borne diseases and foliar application in cereals against foliar and ear pathogens. Full details of the Good Agricultural Practices (GAPs) can be found in the list of end points in Appendix [A](#efs24668-sec-0021){ref-type="sec"}.

Data were submitted to conclude that the representative uses proposed for *P. chlororaphis* strain MA 342 at the EU level result in a sufficient fungicidal efficacy against seed‐borne diseases in cereals, carrots and peas, and against foliar and ear pathogens in cereals, following the guidance document SANCO/10054/2013‐rev. 3 (European Commission, [2013](#efs24668-bib-0009){ref-type="ref"}).

A data gap has been identified for an updated search, including more detailed assessment, of the scientific peer‐reviewed open literature on the active substance and its relevant metabolites, dealing with side effects on non‐target species and published within the last 10 years before the date of submission of dossier, to be conducted and reported in accordance with the Guidance of EFSA on the submission of scientific peer‐reviewed open literature for the approval of pesticide active substances under Regulation (EC) No 1107/2009 (EFSA, [2011](#efs24668-bib-0004){ref-type="ref"}).

*P. chlororaphis* strain MA 342 was discussed at the Pesticides Peer Review TC 139 experts' teleconference on mammalian toxicology, environmental fate and behaviour, and ecotoxicology (September 2016).

Conclusions of the evaluation {#efs24668-sec-0005}
=============================

1. Identity of the microorganism/biological properties/physical and technical properties and methods of analysis {#efs24668-sec-0006}
================================================================================================================

The following guidance documents were followed in the production of this conclusion: SANCO/3029/99‐rev. 4 (European Commission, [2000a](#efs24668-bib-0006){ref-type="ref"}), SANCO/3030/99‐rev. 4 (European Commission, [2000b](#efs24668-bib-0007){ref-type="ref"}), SANCO/825/00‐rev. 8.1 (European Commission, [2010](#efs24668-bib-0008){ref-type="ref"}) and OECD Issue Paper on Microbial Contaminant Limits for Microbial Pest Control Products (OECD, [2011](#efs24668-bib-0015){ref-type="ref"}).

The content of viable cells of *P. chlororaphis* strain MA 342 in the active agent of the microbial pest control product (MPCA) used to produce the plant protection product should be between 1.5 and 3 × 10^13^ CFU/L. 2,3‐deepoxy‐2,3‐didehydro‐rhizoxin (DDR) is considered a relevant impurity with a maximum content of 2 mg/L.

*P. chlororaphis* strain MA 342 can be distinguished from bacterial isolates by restriction fragment length polymorphism (RFLP) analysis and random amplification of polymorphic DNA (RAPD). It should be noted, however, that currently there is no method available to distinguish the *P. chlororaphis* strain MA 342 from all soil bacterial isolates which show similar morphological and biochemical properties and have the same restriction patterns.

*Pseudomonas* strains are known to produce different potentially relevant metabolites (phenazines, 2*R*‐ + 3*R*‐butanediol, 4‐ACPA, HCN, Prn, HPR, HHL, fluorescens insecticidal toxin (Fit)). The absence of *Fit* gene from *P. chlororaphis* strain MA 342 has been confirmed by polymerase chain reaction (PCR). No information is available on production of the other above‐mentioned metabolites by *P. chlororaphis* strain MA 342, as a consequence a data gap was identified to prove that this strain is not producing other (eco)toxicologically relevant secondary metabolites/toxins besides DDR. There is no evidence of direct relationships of *P. chlororaphis* strain MA 342 to known plant, animal or human pathogens. A data gap was identified for the determination of the growth temperatures of *P. chlororaphis* strain MA 342 performed under good laboratory practice (GLP). No growth of the strain was shown below pH 4 or above 10.

The assessment of the data package revealed no issues that need to be included as critical areas of concern with respect to the identity, physical and technical properties of the active substance or the representative formulation; however, a data gap was identified for the determination of the suspensibility of the formulation.

Acceptable methods are available for the determination of the microorganism in the technical material and formulated product and for the determination of the content of contaminating microorganisms. A high‐pressure liquid chromatography--diode array detection (HPLC--DAD) method exists for the determination of DDR on wheat seeds and on plant parts grown from treated barley seeds with a limit of quantification (LOQ) of 1 μg/kg.

2. Mammalian toxicity {#efs24668-sec-0007}
=====================

In the technical product, the metabolite DDR, having genotoxic properties, has to be considered as a toxicologically relevant impurity.

Since 1996, there has been no report on any adverse effect to health related to research, development, handling or production of this strain. In addition to this, no adverse effects have been reported for workers in seed production or farmers who have worked with *P. chlororaphis* strain MA 342 containing products since their introduction in Sweden in 1998.

In the literature, a case of human infection with *P. chlororaphis* was identified in relationship with the presence of a gene responsible of antibioresistance. It should be further investigated if a potential transfer of genetic material will not lead to unacceptable effects on human and animal health, including resistance to known therapeutic substances (data gap, not supported by the RMS).

Several toxicity studies were performed with the microorganism. In a skin sensitisation study (modified Buhler test), negative results were observed; however, considering the limitations of such a study for a microbial and the lack of investigation of the sensitisation by inhalation, the following warning phrase is proposed: '*Pseudomonas chlororaphis* strain MA 342 may have the potential to provoke sensitising reactions'.

The lack of investigations of the infectivity (clearance) in the acute oral toxicity studies was discussed by the experts. No signs of toxicity or pathogenicity were observed in a first acute oral study with rat (LD~50~ \> 2 x 10^10^ bacteria/kg body weight (bw)). Clearance was investigated in a second study and could not be concluded upon due to the limitations of the study (enumeration method and bacterial infection which may have overgrown any *P. chlororaphis* strain MA 342). The experts agreed that a new oral acute toxicity study should be provided to address the infectivity and clearance using validated analytical methods (data gap). Pending on the results of this study and on the confirmation of the growth temperature (see Section [1](#efs24668-sec-0006){ref-type="sec"}), further consideration will have to be given to the possible need for a repeated dose toxicity study. It was also agreed that an intraperitoneal study should not be required because it would represent an unrealistic exposure route. After intratracheal administration (1 × 10^8^ CFU/animal), neither the microorganism nor the formulations were shown to be toxic, pathogenic or infective, and clearance was demonstrated.

The toxicity profile of the metabolite DDR was also discussed by the experts. In a first genotoxicity study (Onfeld, 2000, in Netherlands, [2015](#efs24668-bib-0013){ref-type="ref"}; non‐GLP and not guideline compliant), DDR was demonstrated as being a specific and efficient microtubule inhibitor. In a second *in vivo* micronucleus assay (Abramsson‐Zetterberg, 2000, in Netherlands, [2015](#efs24668-bib-0013){ref-type="ref"}; non‐GLP), a significant increase in the incidence of micronucleated erythrocytes was observed at the high dose only, with high mean DNA content, indicating an aneugenic effect. The experts considered that there was uncertainty in the no observed effect level (NOEL) proposed in the micronucleus assay since an aneugenic effect due to non‐disjunction (as shown in the first study) can be induced at lower concentrations than an aneugenic effect by chromosome loss. As a consequence, a threshold for this genotoxic effect could not be derived on the basis of the available data. It was agreed to propose classification[3](#efs24668-note-1005){ref-type="fn"} for genotoxicity (Mutagen Category 1B). After the meeting, EFSA noted that, following the European Chemicals Agency (ECHA) guidance on the application of the classification, labelling and packaging (CLP) Criteria (ECHA, [2015](#efs24668-bib-0003){ref-type="ref"}), positive results in at least one *in vivo* valid mammalian somatic cell genotoxicity test supported by positive *in vitro* mutagenicity results would trigger the classification in category 2. Accordingly, the proposed classification for DDR is Mutagen Category 2 H341 'Suspected of causing genetic defects'. In order to perform the risk assessment for consumers, derivation of specific reference values should be further considered (data gap, not supported by the RMS).

Other metabolites are known to be produced by *P. chlororaphis* (see Section [1](#efs24668-sec-0006){ref-type="sec"}) but no assessment of their toxicological properties was available (data gap, not supported by the RMS).

For the representative formulated product ('Cerall'), it was considered that the majority of tests performed on the microorganism can be extrapolated to the formulation. An acute pulmonary toxicity/pathogenicity study performed with another formulation ('Cedomon') was also considered relevant for 'Cerall' and showed similar results to those obtained with the microorganism.

For the exposure considerations related to DDR, the experts agreed to use the threshold of toxicological concern (TTC) value for genotoxic compounds and to perform a risk characterisation for operators and bystanders considering exposure levels at the LOQ. The resulting exposure estimates were below the TTC value. For workers (and residents), considering that there is uncertainty in assuming that DDR residues would always be below the LOQ on plants over the period between application and harvest, EFSA considers that the risk assessment cannot be finalised.

Pending on further investigations on toxins/secondary metabolites produced after application, further considerations will have to be given to their potential toxicity in order to conclude on the risk assessment for workers and residents (data gap, not supported by the RMS).

3. Residues {#efs24668-sec-0008}
===========

As it concerns viable residues, the consumer risk assessment for the uses of *P. chlororaphis* strain MA 342 cannot be finalised as long as a conclusion that *P. chlororaphis* strain MA 342 will not lead to unacceptable effects on human health is pending (see Section [2](#efs24668-sec-0007){ref-type="sec"}).

Moreover, in relation to the use of *P. chlororaphis* strain MA 342, non‐viable residues were found to be relevant since a metabolite DDR with mutagenic properties was identified. Studies where levels of the DDR metabolite are investigated in cereals at harvest following foliar application of *P. chlororaphis* strain MA 342 according to the supported GAP were not available in sufficient detail to assess the reliability of the trial results. The information is crucial to assess the consumer exposure potential for the metabolite DDR following foliar application (data gap).

Seed treatment uses are assumed less critical taking into account the much longer period between sowing of treated seeds and harvest of the mature crops as well as growth dilution of potential residues of DDR. This assumption can only hold true if it can be conclusively demonstrated that *P. chlororaphis* strain MA 342 does not have the capacity to translocate to plant parts after seed emergence and to proliferate, which is currently not the case (see Section [4](#efs24668-sec-0009){ref-type="sec"}).

For the seed treatment uses, an indicative assessment was conducted using a TTC~genotox~ of 0.0025 μg/kg bw, assuming residues in the mature cereal crops, peas and carrots growing from treated seeds will contain at the maximum, residue levels at the LOQ of 1 μg/kg applied in the available trials with seed treated cereals. For both the acute and chronic scenario defined in the EFSA PRIMo, the TTC~genotox~ will be exceeded (452% TTC~genotox~ in the chronic scenario with wheat being the main contributor and up to 2,540% TTC~genotox~ in the acute scenario with carrots being the critical commodity). The consumer risk assessment could not be conducted for the foliar application use (more critical use than seed treatment use).

On the basis of the currently available data and information, a refinement of the consumer risk assessment is not possible, and specific toxicological reference values should be derived for the genotoxic metabolite DDR. A critical area of concern was identified as a first tier assessment using the TTC approach failed to demonstrate consumer safety.

4. Environmental fate and behaviour {#efs24668-sec-0009}
===================================

No information has been provided in relation to potential interference of *P. chlororaphis* strain MA 342 with the analytical systems for the control of the quality of drinking water provided for in Directive 98/83/EC[4](#efs24668-note-1006){ref-type="fn"} (as is needed by the decision‐making criteria in Part B of Commission Regulation (EU) No 546/2011[5](#efs24668-note-1007){ref-type="fn"}). Therefore, a data gap has been identified for evidence to demonstrate that no interferences will be produced with methods for the determination of microbiological contamination of water given in Directive 98/83/EC, in particular with the method for the analysis of *Pseudomonas aeruginosa* in drinking water.

Potential transfer of genetic material from *P. chlororaphis* strain MA 342 to other bacteria is considered possible. Information to show that this transfer will not lead to unacceptable effects on the environment would need to be provided (data gap).

EFSA considers a number of statements presented in the old dossier as unreliable (details can be found in the background documents to the EFSA conclusion (EFSA, [2016](#efs24668-bib-0005){ref-type="ref"})). The RMS does not agree on the EFSA conclusion regarding the reliability of non‐GLP data.

4.1. Fate and behaviour in the environment of the microorganism {#efs24668-sec-0010}
---------------------------------------------------------------

Information on persistence and mobility of *P. chlororaphis* strain MA 342 in soil, available in the peer‐reviewed scientific literature, indicates certain capacity to proliferate in soil after application in carrots and onions (Bennett and Whipps, [2008](#efs24668-bib-0001){ref-type="ref"}). This capacity to proliferate has also been observed for other strains of *P. chlororaphis* (Kozdrój et al., [2004](#efs24668-bib-0012){ref-type="ref"}; Das et al., [2008](#efs24668-bib-0002){ref-type="ref"}). Therefore, a data gap has been identified to provide information on viability/population dynamics in several cultivated and uncultivated soils representative of soils typical of the various EU regions where use exists or is anticipated. The provisions on choice of soil and its collection and handling have to be followed. As indicated in Regulation (EU) No 283/2013, test guidelines for chemicals can be adapted for microorganisms as appropriate or other recognised guidance can be used (e.g. US EPA). In this case, for example, the US EPA OPPTS 885.5200 test guideline (US EPA, [1996a](#efs24668-bib-0016){ref-type="ref"}) can be used.

In two reports, not accepted as reliable by EFSA and proposed to be considered as supporting information by the RMS, it is claimed that *P. chlororaphis* strain MA 342 is able to translocate to plant parts, especially to the coleoptile. In a GLP study, analysis of wheat grains produced from seeds treated with *P. chlororaphis* strain MA 342 shows that, at the time of harvest, no bacteria is found in the grains above the LOQ of 1 μg/kg. However, fully reliable studies investigating the presence of *P. chlororaphis* strain MA 342 in other plant parts and different growth stages are not available. Therefore, it is still uncertain to which extent *P. chlororaphis* strain MA 342 can translocate from the roots to other plant parts. A data gap has been identified to provide information in relation to the mobility of the microorganism in the environment.

In relation to the fate and behaviour of *P. chlororaphis* strain MA 342 in water, the experiments available cannot be considered representative of natural water/sediment systems. Therefore, a data gap has been identified to provide information or studies on viability/population dynamics in natural sediment/water systems under both dark and illuminated conditions. As indicated in Regulation (EU) No 283/2013, test guidelines for chemicals can be adapted for microorganisms as appropriate or other recognised guidance can be used (e.g. US EPA). In this case, for example, the OPPTS 885.5300 test guideline (US EPA, [1996b](#efs24668-bib-0017){ref-type="ref"}) can be used.

According to a report provided in the dossier, not accepted as reliable by EFSA and proposed to be considered as supporting information by the RMS, it cannot be excluded that, at least in the closed environments where the seeds are treated, *P. chlororaphis* strain MA 342 can be transported through air.

A data gap has been identified for a reliable study to investigate the range of temperatures where growth of *P. chlororaphis* strain MA 342 may occur (see Section [1](#efs24668-sec-0006){ref-type="sec"}).

4.2. Fate and behaviour in the environment of any relevant metabolite formed by the microorganism under relevant environmental conditions {#efs24668-sec-0011}
-----------------------------------------------------------------------------------------------------------------------------------------

In two peer‐reviewed studies performed with different strains (*P. chlororaphis* strain SRB127; *P. chlororaphis* strain P34), the key role of the metabolites (volatile and non‐volatile antibiotics) in the antifungal activity is demonstrated even in the absence of the live bacteria (Das et al., [2008](#efs24668-bib-0002){ref-type="ref"}; Fürnkranz et al., [2012](#efs24668-bib-0011){ref-type="ref"}). No equivalent study is available for the specific strain *P. chlororaphis* strain MA 342 but a similar mode of action can be assumed. Therefore, a data gap has been identified for the identification and assessment of the toxicological and ecotoxicological relevance of the *P. chlororaphis* strain MA 342 metabolites produced in the environment, including the assessment of potential groundwater exposure (see Section [1](#efs24668-sec-0006){ref-type="sec"}).

5. Ecotoxicology {#efs24668-sec-0012}
================

Suitable studies demonstrating that *P. chlororaphis* strain MA 342 is neither infectious nor pathogenic to **birds** and **wild mammals** were not available. A study demonstrating that *P. chlororaphis* strain MA 342 does not grow at temperatures above 33°C was proposed as a waiver for vertebrates (birds and wild mammals) studies. This study was considered as not valid by the experts at the Pesticides Peer Review teleconference 139. Considering that exposure to *P. chlororaphis* strain MA 342 for birds and mammals could not be excluded for all the representative uses assessed, a data gap was identified for further information to address the infectivity and pathogenicity to birds and wild mammals for *P. chlororaphis* strain MA 342. In the view of reducing testing on vertebrates, as a first step, it may be possible to address this data gap with a new study on the growth temperature of *P. chlororaphis* strain MA 342 (see Section [1](#efs24668-sec-0006){ref-type="sec"}).

The potential for exposure to **aquatic organisms** following the use of *P. chlororaphis* strain MA 342 in seed dressing is deemed to be low; a low risk for this use for aquatic organisms could be concluded.

An acute **fish** study was available in the dossier; this study was considered as not sufficient to address the infectivity and pathogenicity to fish due to its short duration. Literature studies were available demonstrating the natural presence of *P. chlororaphis* in the fish intestine and demonstrating that the use of *P. chlororaphis* as a biocontrol agent did not affect fish. This information was not specific to the strain under evaluation and to the intended uses and was considered as not sufficient to address the risk to fish from *P. chlororaphis* strain MA 342 (data gap).

Regarding **aquatic invertebrates**, the available 21‐day study on *Daphnia magna* was discussed during the Pesticides Peer Review teleconference 139. Considering that i) reproductive effects were not derived from the study; ii) 44% mortality occurred in the tested item group; iii) daphnids in the test item group were reported to be paler and smaller; iv) analytical measurements were performed on fresh samples only, the experts agreed that a data gap should be identified for a new 21‐day study investigating toxicity (including reproductive effects), pathogenicity and infectivity of *P. chlororaphis* strain MA 342 to *D. magna*. In any repeated test, appropriate consideration should be given to the influence of the food quality on daphnids' fitness; in this respect the provisions of the available guideline should be followed. On the basis of the available data a low risk to **algae** for *P. chlororaphis* strain MA 342 was concluded for all representative uses.

An acute (oral and contact) toxicity study for *P. chlororaphis* strain MA 342 on honey**bees** was available. In the study signs of toxicity, infectivity or pathogenicity were not observed. However, the duration of the study (48 h) was considered as not sufficient to address the infectivity and pathogenicity of *P. chlororaphis* strain MA 342 to honeybees. The insecticidal activity of *P. chlororaphis* strain MA 342 was discussed during the Pesticides Peer Review teleconference 139. From the available information, the presence of the genes associated with the insecticidal activity in strain MA 342 cannot be excluded. Also effects of *P. chlororaphis* on Lepidoptera larvae were reported in the literature (Flury et al., [2016](#efs24668-bib-0010){ref-type="ref"}). Several literature studies were available in the RAR indicating that *Pseudomonas* spp. are found living in the gut of arthropods including some bee species. None of these studies were specific to *P. chlororaphis*. Therefore, a data gap was identified to further address the risk to honeybee adults and brood for all representative uses of *P. chlororaphis* strain MA 342. The RMS considered the potential for exposure to bee larvae as questionable and therefore disagreed with this conclusion.

Regarding **non‐target arthropods**, as reported above, the presence of the genes associated with the insecticidal activity in strain MA 342 cannot be excluded. In the absence of additional information to address the toxicity, infectivity and pathogenicity of *P. chlororaphis* strain MA 342, a high risk to non‐target arthropods could not be excluded for all representative uses and a data gap is, therefore, identified.

Suitable studies addressing the toxicity, infectivity and pathogenicity of *P. chlororaphis* strain MA 342 to **earthworms** and **other soil macroorganisms** and the effects on **soil microorganisms** were not available (data gap, not supported by the RMS). *P. chlororaphis* strain MA 342 is a ubiquitous soil bacterium, however, with the available information it cannot be confirmed whether the uses foreseen would trigger a significant increase in the background soil levels of *P. chlororaphis* strain MA 342.

Regarding the secondary metabolite DDR, suitable toxicological studies on non‐target organisms were not available. Considering that exposure cannot be excluded, data gaps were identified to further address the risk for this metabolite to aquatic organisms (relevant for the foliar application use only), to honeybees (adults and brood), to birds and wild mammals (via dietary exposure and via consumption of contaminated water), to non‐target arthropods, and to soil macro‐ and microorganisms (relevant for all representative uses).

From the available information, it cannot be ruled out whether secondary metabolites/toxins, other than DDR, are produced by the *P. chlororaphis* strain MA 342 (see Section [1](#efs24668-sec-0006){ref-type="sec"}).

6. Overview of the risk assessment of compounds listed in residue definitions triggering assessment of effects data for the environmental compartments (Tables [1](#efs24668-tbl-0001){ref-type="table"}, [2](#efs24668-tbl-0002){ref-type="table"}, [3](#efs24668-tbl-0003){ref-type="table"}, [4](#efs24668-tbl-0004){ref-type="table"}--[4](#efs24668-tbl-0004){ref-type="table"}) {#efs24668-sec-0013}
=====================================================================================================================================================================================================================================================================================================================================================================================

###### 

Soil

  Compound (name and/or code)                Persistence   Ecotoxicology
  ------------------------------------------ ------------- ---------------
  *Pseudomonas chlororaphis* strain MA 342   Data gap      Data gap
  Toxins/secondary metabolites               Data gap      Data gap

John Wiley & Sons, Ltd

###### 

Groundwater

+------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------+---------------------+------------------------------------------------------------------------------------------+
| Compound (name and/or code)  | Mobility in soil                                            | \> 0.1 μg/L at 1 m depth for the representative uses[a](#efs24668-note-0005){ref-type="fn"} | Pesticidal activity | Toxicological relevance                                                                  |
+==============================+=============================================================+=============================================================================================+=====================+==========================================================================================+
| Toxins/secondary metabolites | Data gap pending on their identification and quantification | Data gap pending on their identification and quantification                                 | --                  | DDR: genotoxic                                                                           |
|                              |                                                             |                                                                                             |                     |                                                                                          |
|                              |                                                             |                                                                                             |                     | Other potential metabolites: data gap pending on their identification and quantification |
+------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------+---------------------+------------------------------------------------------------------------------------------+

DDR: 2,3‐deepoxy‐2,3‐didehydro‐rhizoxin.

At least one FOCUS scenario or relevant lysimeter.

John Wiley & Sons, Ltd

###### 

Surface water and sediment

  Compound (name and/or code)                Ecotoxicology
  ------------------------------------------ ---------------
  *Pseudomonas chlororaphis* strain MA 342   Data gap
  Metabolites produced in the environment    Data gap

John Wiley & Sons, Ltd

###### 

Air

  Compound (name and/or code)                Toxicology
  ------------------------------------------ --------------------------------------------------------------------
  *Pseudomonas chlororaphis* strain MA 342   Not toxic, pathogenic or infective (NOAEL \> 1 × 10^8^ CFU/animal)

NOAEL: no observed adverse effect level; CFU: colony‐forming units.

John Wiley & Sons, Ltd

7. Data gaps {#efs24668-sec-0014}
============

This is a list of data gaps identified during the peer review process, including those areas in which a study may have been made available during the peer review process but not considered for procedural reasons (without prejudice to the provisions of Article 56 of Regulation (EC) No 1107/2009 concerning information on potentially harmful effects).

An updated search of the scientific peer‐reviewed open literature on the active substance and its relevant metabolites, dealing with side effects on non‐target species and published within the last 10 years before the date of submission of the dossier, to be conducted and reported in accordance with EFSA guidance on the submission of scientific peer‐reviewed open literature for the approval of pesticide active substances under Regulation (EC) No 1107/2009 (EFSA, [2011](#efs24668-bib-0004){ref-type="ref"}). It should be ensured that all relevant studies are included and a more detailed assessment of the literature search is presented (relevant for all representative uses evaluated; submission date proposed by the applicant unknown).Suspensibility of the formulation (relevant for uses evaluated as foliar applications; submission date proposed by the applicant: unknown, see Section [1](#efs24668-sec-0006){ref-type="sec"}).Applicant to provide a study on the determination of the growth temperatures of *P. chlororaphis* strain MA 342 (in order the study can be used also for human health evaluation it would need to be performed under GLP) (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Sections [1](#efs24668-sec-0006){ref-type="sec"}, [2](#efs24668-sec-0007){ref-type="sec"}, [4](#efs24668-sec-0009){ref-type="sec"} and [5](#efs24668-sec-0012){ref-type="sec"}).Applicant to submit laboratory and/or field studies or reliable scientific information where levels of DDR and other potential secondary metabolites/toxins are investigated (including an assessment of their toxicological and ecotoxicological relevance), using appropriately validated analytical methods, in soil and plants following applications of *P. chlororaphis* strain MA 342 according to the supported GAPs (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Sections [1](#efs24668-sec-0006){ref-type="sec"}, [2](#efs24668-sec-0007){ref-type="sec"}, [4](#efs24668-sec-0009){ref-type="sec"} and [5](#efs24668-sec-0012){ref-type="sec"}).Applicant to provide information to show that potential transfer of genetic material from *P. chlororaphis* strain MA 342 will not lead to adverse effects on human and animal health, including resistance to known therapeutics, and will not lead to unacceptable effects on the environment (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Sections [2](#efs24668-sec-0007){ref-type="sec"} and [4](#efs24668-sec-0009){ref-type="sec"}).Acute oral toxicity study addressing the infectivity and clearance of *P. chlororaphis* strain MA 342 after administration using validated analytical methods (relevant for all representative uses evaluated; study ongoing, submission date proposed by the applicant: study ongoing and expected in 2017; see Section [2](#efs24668-sec-0007){ref-type="sec"}).Derivation of specific reference values for the metabolite DDR should be further considered for the consumers' risk assessment (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Sections [2](#efs24668-sec-0007){ref-type="sec"} and [3](#efs24668-sec-0008){ref-type="sec"}).Applicant to submit full details on residue trials where levels of the DDR metabolite are investigated in cereals at harvest following foliar application of *P. chlororaphis* strain MA 342 according to the supported GAP (relevant for uses evaluated as foliar applications; submission date proposed by the applicant: unknown, see Section [3](#efs24668-sec-0008){ref-type="sec"}).Applicant to provide information in relation to potential interferences of *P. chlororaphis* strain MA 342 with the analytical systems for the control of the quality of drinking water in particular with the method for the analysis of *P. aeruginosa* in drinking water (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [4](#efs24668-sec-0009){ref-type="sec"}).Applicant to provide information or studies regarding viability/population dynamics in several cultivated and uncultivated soils representative of soils typical of the various EU regions where use exists or is anticipated, and in natural sediment/water systems under both dark and illuminated conditions. Test guidelines for chemicals can be adapted for microorganisms as appropriate or other recognised guidance can be used (e.g. US EPA). In this case, the US EPA OPPTS 885.5200 and OPPTS 885.5300 test guidelines could be used (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [4](#efs24668-sec-0009){ref-type="sec"}).Applicant to provide information in relation to the mobility of the microorganism in the environment (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [4](#efs24668-sec-0009){ref-type="sec"}).Further information to address the risk to birds and wild mammals from *P. chlororaphis* strain MA 342. In the view of reducing testing on vertebrates, as a first step, it may be possible to address this data gap with a new study on the growth temperature of *P. chlororaphis* strain MA 342 (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Sections [1](#efs24668-sec-0006){ref-type="sec"} and [5](#efs24668-sec-0012){ref-type="sec"}).Further information to address risk to fish and aquatic invertebrates (relevant for the use as foliar application) and to honeybees (adult and brood) and other non‐target arthropods, soil macro‐ and microorganisms for *P. chlororaphis* strain MA 342 (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [5](#efs24668-sec-0012){ref-type="sec"}).Further information to address the risk from the secondary metabolite DDR to aquatic organisms (relevant for the foliar application use), to birds and wild mammals (via dietary exposure and via consumption of contaminated water), to honeybees and other non‐target arthropods, and to soil macro‐ and microorganisms (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [5](#efs24668-sec-0012){ref-type="sec"}).

8. Particular conditions proposed to be taken into account to manage the risk(s) identified {#efs24668-sec-0015}
===========================================================================================

No particular conditions are proposed for the representative uses evaluated.

9. Concerns {#efs24668-sec-0016}
===========

9.1. Issues that could not be finalised {#efs24668-sec-0017}
---------------------------------------

An issue is listed as 'could not be finalised' if there is not enough information available to perform an assessment, even at the lowest tier level, for the representative uses in line with the uniform principles in accordance with Article 29(6) of Regulation (EC) No 1107/2009 and as set out in Commission Regulation (EU) No 546/2011 and if the issue is of such importance that it could, when finalised, become a concern (which would also be listed as a critical area of concern if it is of relevance to all representative uses).

An issue is also listed as 'could not be finalised' if the available information is considered insufficient to conclude on whether the active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.

The assessment of potential transfer of genetic material (e.g. responsible of antibioresistance) from *P. chlororaphis* strain MA 342 to other organisms could not be finalised.The production of toxins/secondary metabolites cannot be excluded. Therefore, the risk assessment could not be finalised for workers, residents, consumers and the environment including the assessment of potential groundwater exposure.Risk assessment for workers and residents exposed to the genotoxic metabolite DDR could not be concluded on the basis of the available data.Potential interferences of *P. chlororaphis* strain MA 342 with the analytical systems for the control of the quality of drinking water could not be excluded.A high risk to non‐target arthropods following the exposure to *P. chlororaphis* strain MA 342 and its secondary metabolite DDR could not be excluded.

9.2. Critical areas of concern {#efs24668-sec-0018}
------------------------------

An issue is listed as a critical area of concern if there is enough information available to perform an assessment for the representative uses in line with the uniform principles in accordance with Article 29(6) of Regulation (EC) No 1107/2009 and as set out in Commission Regulation (EU) No 546/2011, and if this assessment does not permit the conclusion that, for at least one of the representative uses, it may be expected that a plant protection product containing the active substance will not have any harmful effect on human or animal health or on groundwater, or any unacceptable influence on the environment.

An issue is also listed as a critical area of concern if the assessment at the higher tier level could not be finalised due to lack of information, and if the assessment performed at the lower tier level does not permit the conclusion that, for at least one of the representative uses, it may be expected that a plant protection product containing the active substance will not have any harmful effect on human or animal health or on groundwater, or any unacceptable influence on the environment.

An issue is also listed as a critical area of concern if, in the light of current scientific and technical knowledge using guidance documents available at the time of application, the active substance is not expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.

A refinement of the consumer risk assessment is currently not possible in the absence of specific toxicological reference values for the genotoxic metabolite DDR. A first tier assessment using the TTC approach failed to demonstrate consumer safety.

9.3. Overview of the concerns identified for each representative use considered (Table [5](#efs24668-tbl-0005){ref-type="table"}) {#efs24668-sec-0019}
---------------------------------------------------------------------------------------------------------------------------------

(If a particular condition proposed to be taken into account to manage an identified risk, as listed in Section [8](#efs24668-sec-0015){ref-type="sec"}, has been evaluated as being effective, then 'risk identified' is not indicated in Table [5](#efs24668-tbl-0005){ref-type="table"}.)

###### 

Overview of concerns

  Representative use                                                         Cereals Seed treatment            Carrots Seed treatment   Peas Seed treatment   Cereals Foliar application   
  -------------------------------------------------------------------------- --------------------------------- ------------------------ --------------------- ---------------------------- ------
  **Operator risk**                                                          Risk identified                                                                                               
  Assessment not finalised                                                                                                                                                                 
  **Worker risk**                                                            Risk identified                                                                                               
  Assessment not finalised                                                   X^2,3^                            X^2,3^                   X^2,3^                X^2,3^                       
  **Resident/bystander risk**                                                Risk identified                                                                                               
  Assessment not finalised                                                   X^2,3^                            X^2,3^                   X^2,3^                X^2,3^                       
  **Consumer risk**                                                          Risk identified                   X^6^                     X^6^                  X^6^                         X^6^
  Assessment not finalised                                                   X^2^                              X^2^                     X^2^                  X^2^                         
  **Risk to wild non‐target terrestrial vertebrates**                        Risk identified                                                                                               
  Assessment not finalised                                                                                                                                                                 
  **Risk to wild non‐target terrestrial organisms other than vertebrates**   Risk identified                                                                                               
  Assessment not finalised                                                   X^5^                              X^5^                     X^5^                  X^5^                         
  **Risk to aquatic organisms**                                              Risk identified                                                                                               
  Assessment not finalised                                                                                                                                                                 
  **Groundwater exposure to active substance**                               Legal parametric value breached                                                                               
  Assessment not finalised                                                                                                                                                                 
  **Groundwater exposure to metabolites**                                    Legal parametric value breached                                                                               
  Parametric value of 10 μg/L breached                                                                                                                                                     
  Assessment not finalised                                                   X^2^                              X^2^                     X^2^                  X^2^                         

Columns are grey if no safe use can be identified. The superscript numbers relate to the numbered points indicated in Sections [9.1](#efs24668-sec-0017){ref-type="sec"} and [9.2](#efs24668-sec-0018){ref-type="sec"}. Where there is no superscript number, see Sections [2](#efs24668-sec-0007){ref-type="sec"}, [3](#efs24668-sec-0008){ref-type="sec"}, [4](#efs24668-sec-0009){ref-type="sec"}, [4.1](#efs24668-sec-0010){ref-type="sec"}, [4.2](#efs24668-sec-0011){ref-type="sec"}, [5](#efs24668-sec-0012){ref-type="sec"}--[6](#efs24668-sec-0013){ref-type="sec"} for further information.

John Wiley & Sons, Ltd

Abbreviations {#efs24668-sec-0020}
=============

bwbody weightCLPclassification, labelling and packagingCFUcolony‐forming unitsDDR2,3‐deepoxy‐2,3‐didehydro‐rhizoxinECHAEuropean Chemicals AgencyEECEuropean Economic CommunityEFSA PRIMoEFSA Pesticide Residue Intake ModelFAOFood and Agriculture Organization of the United NationsFitfluorescens insecticidal toxinFOCUSForum for the Co‐ordination of Pesticide Fate Models and their UseFSflowable concentrate for seed treatmentGAPGood Agricultural PracticeGLPgood laboratory practiceHPLC‐DADhigh‐pressure liquid chromatography‐diode array detectionLD~50~lethal dose, median; dosis letalis mediaLOQlimit of quantificationMPCAactive agent of the microbial pest control productMPCPmicrobial pest control productNCIMBUK National Collection of Industrial and Marine Bacteria LtdNOAELno observed adverse effect levelNOELno observed effect levelOECDOrganisation for Economic Co‐operation and DevelopmentPCRpolymerase chain reactionRAPDrandom amplification of polymorphic DNARARrenewal assessment reportRFLPrestriction fragment length polymorphismSMILESsimplified molecular‐input line‐entry systemTTCthreshold of toxicological concernWHOWorld Health OrganizationUS EPAUS Environmental Protection Agency

Appendix A -- List of end points for the active substance and the representative formulation {#efs24668-sec-0021}
============================================================================================

Appendix A can be found in the online version of this output ('Supporting information' section): <https://doi.org/10.2903/j.efsa.2017.4668>.

Appendix B -- Used compound codes {#efs24668-sec-0022}
=================================

Code/trivial nameChemical name/SMILES notationStructural formula**DDR** **2,3‐Deepoxy‐2,3‐didehydro‐rhizoxin**(1*R*,2*R*,3*E*,5*R*,7*R*,8*S*,10*S*,13*E*,16*R*)‐8‐Hydroxy‐10‐\[(2*S*,3*R*,4*E*,6*E*,8*E*)‐3‐methoxy‐4,8‐dimethyl‐9‐(2‐methyl‐1,3‐oxazol‐4‐yl)nona‐4,6,8‐trien‐2‐yl\]‐2,7‐dimethyl‐6,11,19‐trioxatricyclo\[14.3.1.0^5,7^\]icosa‐3,13‐diene‐12,18‐dione Cc1occ(n1)\\C=C(/C)\\C=C\\C=C(/C)\[C\@H\](OC)\[C@\@H\](C)\[C\@H\]3OC(=O)C=CC\[C\@H\]2CC(=O)O\[C\@H\](C2)\[C\@H\](C)C=C\[C\@H\]4O\[C@\]4(C)\[C@\@H\](O)C3![](EFS2-15-e04668-g001.jpg "image")**4‐ACPA**4‐Carbamoylphenyl acetate O=C(C)Oc1ccc(cc1)C(N)=O![](EFS2-15-e04668-g002.jpg "image")**HCN** **Hydrogen cyanide**Hydrocyanic acid N\#C![](EFS2-15-e04668-g003.jpg "image")**2R‐3R‐Butanediol**(2*R*,3*R*)‐Butane‐2,3‐diol C\[C@\@H\](O)\[C@\@H\](C)O![](EFS2-15-e04668-g004.jpg "image")**Prn** **Pyrrolnitrin**3‐Chloro‐4‐(3‐chloro‐2‐nitrophenyl)‐1*H*‐pyrrole Clc2cncc2c1cccc(Cl)c1\[N+\](\[O‐\])=O![](EFS2-15-e04668-g005.jpg "image")**HPR** **2‐Hexyl‐5‐propyl‐resorcinol**2‐Hexyl‐5‐propylbenzene‐1,3‐diol Oc1cc(cc(O)c1CCCCCC)CCC![](EFS2-15-e04668-g006.jpg "image")**HHL** ***N*‐Hexanoyl homoserine lactone***N*‐\[(3*S*)‐2‐Oxotetrahydrofuran‐3‐yl\]hexanamide O=C1OCC\[C@\@H\]1NC(=O)CCCCC![](EFS2-15-e04668-g007.jpg "image")[^1]

Supporting information
======================

###### 

List of end points for the active substance and the representative formulation

###### 

Click here for additional data file.

Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market. OJ L 252, 19.9.2012, p. 26--32.

Regulation (EC) No 1107/2009 of 21 October 2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ L 309, 24.11.2009, p. 1--50.

It should be noted that harmonised classification and labelling is formally proposed and decided in accordance with Regulation (EC) No 1272/2008. Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006. OJ L 353, 31.12.2008, p. 1--1355.

Council Directive 98/83/EC of 3 November 1998 on the quality of water intended for human consumption. OJ L 330, 5.12.1998, p. 32--54.

Commission Regulation (EU) No 546/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards uniform principles for evaluation and authorisation of plant protection products. OJ L 155, 11.6.2011, p. 127--175.

[^1]: SMILES: simplified molecular‐input line‐entry system.
